Summit Partners

PE Solo Angel Boston, MA, United States · Founded 1984

Website

Summit Partners targets majority and minority growth equity investments in category-leading, profitable healthcare, life sciences, and technology companies globally. The firm partners with exceptional management teams to scale operations, optimize revenue, and accelerate long-term expansion.

About Summit Partners

Summit Partners is a long-established global growth equity firm with offices in Boston, Menlo Park, and London, investing in profitable or near-profitable companies across technology, healthcare, financial services, and consumer sectors. The firm operates at growth and late stages with check sizes typically beginning at fifteen to twenty-five million dollars and scaling well into nine figures for larger transactions, including minority growth investments, recapitalizations, and selective buyouts. Healthcare is a meaningful focus area for Summit, with a portfolio that has historically included healthcare services, healthcare technology, and life sciences tools companies. The natural fit is a healthcare or healthcare-adjacent company with material revenue, profitability or a clear path to profitability, and ambitions for either organic acceleration or a buy-and-build strategy. AI-native healthcare companies can engage at the growth stage if there is meaningful enterprise traction, defensible economics, and a credible plan for capital deployment. Pre-revenue companies, deep biopharma research-stage assets, and seed-stage software businesses are out of scope and should look to early-stage investors. Founders should expect rigorous, finance-led diligence with full audit support, careful go-to-market analysis, and active engagement on operations, M&A, and management team build-out post-investment. The best entry path is via a growth equity banker, a strategic advisor with Summit relationships, or a warm introduction from a portfolio CEO. Direct outreach to partners is also a credible path when the company is at clear growth-stage scale.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Share your experience

At a glance

Type PE

Stages Growth, Seed, Series A

Check size <$250k

Sub-verticals Care Delivery / Tech-Enabled Services, Diagnostics, Digital Health

HQ Boston, MA, United States

Founded 1984

Visit website

Healthcare AI tools backed by Summit Partners

Tools made by companies in Summit Partners's portfolio that we cover in the directory.

MEDITECH Expanse

MEDITECH

Documentation & Scribing

MEDITECH Expanse is an AI-native EHR with integrated AI capabilities like ambient scribing, patient portal and clinician chatbots, and AI-powered no-show predictions, designed to improve physician experience and efficiency across various care settings.

Contact for pricing

Ambient Scribe for Physicians and Nurses

MEDITECH

Clinical Decision Support & Reference

MEDITECH's Ambient Scribe for Physicians and Nurses uses AI to convert patient-provider conversations into clinical documentation within the EHR, aiming to reduce administrative burden and improve efficiency.

Quote-based, estimated ~$369-$800+ per provider per month for enterprise, ehr-integrated systems, plus implementation fees and multi-year contracts.

AI Agent for Claims Denials and Appeals

MEDITECH

EMR / EHR Systems

MEDITECH's AI Agent for Claims Denials and Appeals automates and streamlines the revenue cycle process, specifically targeting claims denials and appeals within the MEDITECH Expanse EHR.

Starts at $400-$500/month per provider, with significant additional costs for implementation and infrastructure.

AI tool for querying patient records

MEDITECH

Clinical Decision Support & Reference

MEDITECH Expanse integrates AI to enable physicians to efficiently query patient records, enhance clinical decision-making, and streamline workflows within a comprehensive EHR system.